Evaluation of peptidylarginine deiminase 4 and PADI4 polymorphisms in sepsis-induced acute kidney injury

التفاصيل البيبلوغرافية
العنوان: Evaluation of peptidylarginine deiminase 4 and PADI4 polymorphisms in sepsis-induced acute kidney injury
المؤلفون: Leonardo A. M. Zornoff, Bertha F. Polegato, Daniela Ponce, Marcos F. Minicucci, Ana Lúcia Gut, Paula S. Azevedo, André Luis Balbi, Sergio A. R. Paiva, N.A. Costa, Amanda Gomes Pereira
المساهمون: Universidade Federal de Goiás (UFG), Universidade Estadual Paulista (Unesp)
المصدر: Revista da Associação Médica Brasileira, Vol 66, Iss 11, Pp 1515-1520 (2020)
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Revista da Associação Médica Brasileira, Volume: 66, Issue: 11, Pages: 1515-1520, Published: 02 DEC 2020
Revista da Associação Médica Brasileira v.66 n.11 2020
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
بيانات النشر: Associação Médica Brasileira, 2020.
سنة النشر: 2020
مصطلحات موضوعية: medicine.medical_specialty, Medicine (General), medicine.medical_treatment, Sepse, Gastroenterology, Sepsis, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Protein-arginine deiminase type 4, R5-920, Polymorphism (computer science), Internal medicine, medicine, Humans, Renal replacement therapy, Mortality, Dialysis, 030304 developmental biology, 0303 health sciences, Creatinine, Septic shock, business.industry, Acute kidney injury, 030208 emergency & critical care medicine, General Medicine, medicine.disease, Renal Replacement Therapy, Intensive Care Units, chemistry, Proteína-arginina desiminase do tipo 4, PADI4, Mortalidade, Protein-Arginine Deiminases, Lesão renal aguda, business, Diálise
الوصف: SUMMARY BACKGROUND: The aim of this study is to evaluate the peptidylarginine deiminase 4 (PAD 4) concentration and PADI4 polymorphisms as predictors of acute kidney injury (AKI) development, the need for renal replacement therapy (RRT), and mortality in patients with septic shock. METHODS: We included all individuals aged ≥ 18 years, with a diagnosis of septic shock at ICU admission. Blood samples were taken within the first 24 hours of the patient's admission to determine serum PAD4 concentration and its PADI4 polymorphism (rs11203367) and (rs874881). Patients were monitored during their ICU stay and the development of SAKI was evaluated. Among the patients in whom SAKI developed, mortality and the need for RRT were also evaluated. RESULTS: There were 99 patients, 51.5% of whom developed SAKI and of these, 21.5% needed RRT and 80% died in the ICU. There was no difference between PAD4 concentration (p = 0.116) and its polymorphisms rs11203367 (p = 0.910) and rs874881 (p = 0.769) in patients in whom SAKI did or did not develop. However, PAD4 had a positive correlation with plasma urea concentration (r = 0.269 and p = 0.007) and creatinine (r = 0.284 and p = 0.004). The PAD4 concentration and PADI4 polymorphisms were also not associated with RRT and with mortality in patients with SAKI. CONCLUSION: PAD4 concentration and its polymorphisms were not associated with SAKI development, the need for RRT, or mortality in patients with septic shock. However, PAD4 concentrations were associated with creatinine and urea levels in these patients. RESUMO OBJETIVO: Avaliar a concentração da peptidilarginina deiminase 4 (PAD4) e os polimorfismos de PADI4, como preditores de desenvolvimento de lesão renal aguda, necessidade de terapia renal substitutiva (TRS) e mortalidade em pacientes com choque séptico. MÉTODOS: Foram incluídos indivíduos com idade ≥18 anos, com diagnóstico de choque séptico na admissão na Unidade de Terapia Intensiva (UTI). Amostras de sangue foram coletadas nas primeiras 24 horas após a admissão do paciente para determinar a concentração sérica de PAD4 e seus polimorfismos PADI4 (rs11203367) e (rs874881). Os pacientes foram acompanhados durante a internação na UTI e tiveram avaliados desenvolvimento da lesão renal aguda séptica (Sepsis-induced acute kidney injury - Saki), necessidade TRS e mortalidade. RESULTADOS: Foram avaliados 99 pacientes; 51,5% desenvolveram Saki e, desses, 21,5% necessitaram de TRS e 80% morreram na UTI. Não houve diferença entre a concentração de PAD4 (p=0,116) e seus polimorfismos rs11203367 (p=0,910) e rs874881 (p=0,769) entre os pacientes. No entanto, o PAD4 apresentou correlação positiva com a concentração plasmática de ureia (r=0,269; p=0,007) e creatinina (r=0,284; p=0,004). A concentração de PAD4 e os polimorfismos da PADI4 também não foram associados à TRS e à mortalidade em pacientes com Saki. CONCLUSÕES: A concentração de PAD4 e seus polimorfismos não foram associados ao desenvolvimento de Saki, à necessidade de TRS ou à mortalidade em pacientes com choque séptico. No entanto, as concentrações de PAD4 foram associadas às concentrações de creatinina e ureia nesses pacientes.
وصف الملف: text/html
اللغة: English
تدمد: 1806-9282
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3d38b9b0f7a3f8b9ce8d13b8b2973a5
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302020001101515&tlng=en
Rights: OPEN
رقم الانضمام: edsair.doi.dedup.....f3d38b9b0f7a3f8b9ce8d13b8b2973a5
قاعدة البيانات: OpenAIRE